CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
2.040
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:03 AM EST

CytomX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44572281104106283
Market Cap Growth
-37.95%795.45%-22.37%-1.80%-62.58%-6.69%
Enterprise Value
101584-26-75-7069
Last Close Price
2.044.261.031.551.604.33

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.53---
Forward PE
-3.0347.9916.30--
PS Ratio
31.709.470.581.031.997.57
PB Ratio
1.567.29-176.77-2.19-1.23-615.53
P/TBV Ratio
1.577.39----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.217.66---1.84

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.04-20.58-0.29-0.21-47.22
Debt / EBITDA Ratio
--0.29---
Net Debt / Equity Ratio
-1.21-1.34200.083.382.05617.76
Net Debt / EBITDA Ratio
3.677.30-3.4137.261.922.50
Net Debt / FCF Ratio
6.741.751.052.821.562.35
Asset Turnover
0.050.560.860.440.180.11
Quick Ratio
7.702.981.211.141.513.93
Current Ratio
7.823.091.251.171.553.99
Return on Equity (ROE)
-43.55%-35.25%----
Return on Assets (ROA)
-22.68%-8.99%9.69%-1.75%-19.54%-20.78%
Return on Invested Capital (ROIC)
--61.56%1.44%-50.75%-42.04%
Return on Capital Employed (ROCE)
-29.70%-18.60%71.90%-14.10%-86.70%-44.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.28%-2.41%39.54%-0.55%-93.93%-41.01%
FCF Yield
-11.47%-10.50%-107.36%-54.78%-106.42%-42.70%
Buyback Yield / Dilution
-66.32%-62.77%-14.82%-12.27%-2.48%-39.01%
SEC Filings: 10-K · 10-Q